AI Summary
We reviewed 137 live results for leuco plus (filgrastim) and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biosimilar and Immunostimulant.
Comparison Table
Recommended
Leuco-Plus (filgrastim)
Source: Siam Bioscience Co., Ltd.
Description
Leuco-Plus is a locally manufactured filgrastim biosimilar used for the treatment of neutropenia. It is available in prefilled syringes in strengths of 300 µg/1 ml and 480 µg/1.6 ml, providing a convenient delivery method for stimulating white blood cell production.
Best for
local supply reliability, prefilled syringe preference, cost-effective filgrastim and chemotherapy patients
View Details
Rating
Neupogen (filgrastim)
Source: Amgen
Description
Neupogen is the reference biologic (originator) medication containing recombinant filgrastim. It is used to stimulate bone marrow to produce white blood cells to prevent infections in patients with non-myeloid malignancies receiving myelosuppressive therapy.
Best for
reference biologic preference, established clinical protocols, severe chronic neutropenia and specialized oncology clinics
View Details
Rating
Neupogen (Filgrastim)
Source: Amgen
Description
A recombinant-methionyl human granulocyte colony-stimulating factor (r-metHuG-CSF) provided in pre-filled syringes. This haematopoietic agent is used to treat neutropenia and reduce the risk of infection in patients undergoing cancer treatments.
Best for
chemotherapy patients, neutropenia management, infection prevention and haematology support
View Details
Rating
| Compare | Leuco-Plus (filgrastim) | Neupogen (filgrastim) | Neupogen (Filgrastim) |
|---|---|---|---|
| Source | Siam Bioscience Co., Ltd. | Amgen | Amgen |
| Description | Leuco-Plus is a locally manufactured filgrastim biosimilar used for the treatment of neutropenia. It is available in prefilled syringes in strengths of 300 µg/1 ml and 480 µg/1.6 ml, providing a convenient delivery method for stimulating white blood cell production. | Neupogen is the reference biologic (originator) medication containing recombinant filgrastim. It is used to stimulate bone marrow to produce white blood cells to prevent infections in patients with non-myeloid malignancies receiving myelosuppressive therapy. | A recombinant-methionyl human granulocyte colony-stimulating factor (r-metHuG-CSF) provided in pre-filled syringes. This haematopoietic agent is used to treat neutropenia and reduce the risk of infection in patients undergoing cancer treatments. |
| Best for | local supply reliability, prefilled syringe preference, cost-effective filgrastim and chemotherapy patients | reference biologic preference, established clinical protocols, severe chronic neutropenia and specialized oncology clinics | chemotherapy patients, neutropenia management, infection prevention and haematology support |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Leuco-Plus (filgrastim) from Siam Bioscience Co., Ltd.."
I picked this because As a locally produced biosimilar in Thailand, it offers reliable domestic availability and competitive pricing for critical oncology support.
Share this search
Related Finds